Caisse Des Depots Et Consignations’s Vir Biotechnology VIR Stock Holding History

Caisse Des Depots Et Consignations’s Portfolio VIR Stock Details VIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$512K	Buy	+50,235	New	+$478K	0.01%	206

Other funds holding VIR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AVM

Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

GSK plc London $602M AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Caisse Des Depots Et Consignations's VIR Position: Q2 2026 in Review

Caisse Des Depots Et Consignations opened a new position in Vir Biotechnology (VIR) in Q2 2026: 50,235 shares worth $512K. The stake represents 0.01% of the portfolio and ranks #206 among its holdings.

237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

Caisse Des Depots Et Consignations held 50,235 shares of Vir Biotechnology worth $512K as of Q2 2026.
Vir Biotechnology was a new Caisse Des Depots Et Consignations position in Q2 2026.
Vir Biotechnology made up 0.01% of Caisse Des Depots Et Consignations's portfolio in Q2 2026, its #206 holding.
237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Caisse Des Depots Et Consignations's 13F filing for Q2 2026, filed 24 Jul 2026.